Active Ingredient: LINAGLIPTIN
Proprietary Name: LINAGLIPTIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A208335
Product Number: 001
Approval Date: Aug 31, 2021
Applicant Holder Full Name: SUNSHINE LAKE PHARMA CO LTD
Marketing Status:
Prescription
Patent and Exclusivity Information